A genome-wide study identified specific dex-induced GR target genes, involved in tumor cell survival and chemotherapy resistance, EMT, chromatin remodeling, and epithelial cell/inflammatory cell interactions, suggesting the involvement of GR in the aggressive behavior of ERα-negative BCs [96]. Here, NR3C1 is linked to neoplasm.